Achillion shares rise on hepatitis C drug data
Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive "proof-of-concept" results, while meeting safety and tolerabi...
Yahoo! News